James E. Flynn - Significant Ownership

Signature - Title
James E. Flynn - Jonathan Isler, Attorney-in-Fact
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by James E. Flynn.

Significant Ownership of James E. Flynn

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OMIC Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share 100% $20K -$4.97M 1K -99.6% Deerfield Mgmt IV, L.P. Feb 21, 2025
NUVL Nuvalent, Inc. Class A common stock, $0.0001 par value per share 27.59% $1.76B 23.6M Deerfield Management Company, L.P. Dec 31, 2024
SPRY ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 10.72% $126M 10.5M Deerfield Management Company, L.P. Mar 20, 2025
PHGE BiomX Inc. Common Stock, par value $0.0001 per share 9.99% $11.4M 15.6M Deerfield Management Company, L.P. Feb 27, 2025
AFIB Acutus Medical, Inc. Common Stock, par value $0.001 per share 9.1% $275K 5.49M James E. Flynn Jan 27, 2025
INDV Indivior PLC Ordinary Shares, $0.50 nominal value per share 7.16% $86.7M 8.88M Deerfield Mgmt, L.P. Dec 31, 2024
DCGO DocGo Inc. Common Stock 4.95% $15.3M 5.05M Deerfield Mgmt, L.P. Feb 13, 2025
ALHC Alignment Healthcare, Inc. Common Stock 3.81% $110M 7.3M Deerfield Mgmt, L.P. Dec 31, 2024
CPRX Catalyst Pharmaceuticals, Inc. Common Stock 2.63% $66.4M 3.13M Deerfield Mgmt, L.P. Dec 31, 2024
VTYX Ventyx Biosciences, Inc. Common Stock 0.76% $765K 535K Deerfield Mgmt, L.P. Dec 31, 2024
PRLD Prelude Therapeutics Incorporated Common Stock 0% $0 0 Deerfield Mgmt, L.P. Dec 31, 2024
KURA Kura Oncology, Inc. Common Stock 0% $0 0 Deerfield Mgmt, L.P. Dec 31, 2024

Schedules 13D/G Reported by James E. Flynn:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.